Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 13/20 | 0.82 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.53 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8775856 | 1.00 | TBXAS1 (0.82) | TBXAS1EPHX2TBXA2RCYP2C9CYP2C19 | |
| SCHEMBL8775812 | 0.90 | TBXAS1 (0.65) | TBXAS1EPHX2CYP2C9CYP2C19PDE4D | |
| SCHEMBL8775878 | 0.82 | TBXAS1 (0.71) | TBXAS1EPHX2TBXA2RCYP2C9CYP2C19 | |
| SCHEMBL8775940 | 0.82 | TBXAS1 (0.71) | TBXAS1EPHX2TBXA2RCYP2C9CYP2C19 | |
| SCHEMBL8775786 | 0.82 | TBXAS1 (0.71) | TBXAS1EPHX2TBXA2RCYP2C9CYP2C19 | |
| SCHEMBL8775886 | 0.80 | TBXAS1 (0.68) | TBXAS1EPHX2TBXA2RCYP2C9CYP2C19 | |
| SCHEMBL14288463 | 0.80 | TBXAS1 (0.64) | TBXAS1EPHX2CYP2C9CYP2C19PDE4D | |
| SCHEMBL9549607 | 0.79 | TBXAS1 (0.74) | TBXAS1TBXA2R | |
| SCHEMBL9910965 | 0.79 | TBXAS1 (0.61) | TBXAS1EPHX2CYP2C9CYP2C19PDE4D | |
| SCHEMBL8775954 | 0.78 | TBXAS1 (0.66) | TBXAS1EPHX2TBXA2RCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0807626-A1 | N-HYDROXYUREA DERIVATIVES | Nikken Chemicals Company, Limited (JP) | 1997-11-19 | — | — | EP | disclosed |